Affiliations 

  • 1 Non-Destructive Biomedical and Pharmaceutical Research Centre, Smart Manufacturing Research Institute, Universiti Teknologi MARA Selangor, 42300 Puncak Alam, Selangor, Malaysia; Particle Design Research Group, Faculty of Pharmacy, Universiti Teknologi MARA Selangor, 42300 Puncak Alam, Selangor, Malaysia
  • 2 Taab Biostudy Services, Jadavpur University, Jadavpur, Kolkata 32, India
  • 3 Non-Destructive Biomedical and Pharmaceutical Research Centre, Smart Manufacturing Research Institute, Universiti Teknologi MARA Selangor, 42300 Puncak Alam, Selangor, Malaysia; Food and Drug Department, University of Parma, Parma, Italy
  • 4 InQpharm Group Sdn Bhd, Plaza Mont Kiara, 2, Jalan Kiara, 50480 Kuala Lumpur, Malaysia
  • 5 InQPharm Consumer Health GmbH, Waldseeweg 6, 13467 Berlin, Germany
  • 6 Food and Drug Department, University of Parma, Parma, Italy; PlumeStars srl, Parma, Italy
  • 7 Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy
  • 8 Non-Destructive Biomedical and Pharmaceutical Research Centre, Smart Manufacturing Research Institute, Universiti Teknologi MARA Selangor, 42300 Puncak Alam, Selangor, Malaysia; Particle Design Research Group, Faculty of Pharmacy, Universiti Teknologi MARA Selangor, 42300 Puncak Alam, Selangor, Malaysia. Electronic address: wongtinwui@uitm.edu.my
Int J Pharm, 2022 Nov 25;628:122226.
PMID: 36191818 DOI: 10.1016/j.ijpharm.2022.122226

Abstract

Dome matrix was designed with gastric and intestinal targeting capacities using melatonin and caffeine as model drugs, and alginate, chitosan and cellulose as composite materials. The melatonin, caffeine and intermediate hydroxypropylmethylcelluose-based dispersible modules were prepared through compaction. Caffeine piled module was capped at both ends with melatonin void modules via intermediate dispersible modules into Dome matrix. Dispersion of intermediate module detached melatonin module from Dome matrix and had it floated in stomach providing a more complete melatonin release due to favorable pH-pKa relationship of dissolution medium and drug. With reference to the caffeine module, the detachment of melatonin module facilitated its gastrointestinal transit as a reduced size matrix, with majority of caffeine delivered in colon. The dual site-targeted and -release Dome matrix is applicable as reference oral carrier for pharmaceutical, nutraceutical, functional food and veterinary medicine where a complex formulation and performancein vivoare required.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.